Capital Building in Washington DC

Advocacy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • Health Groups Oppose Suspending Immigration

    The Association for Clinical Oncology signed on to a letter from the American Medical Association expressing concerns about the Trump Administration’s executive order suspending immigration on certain professional visas to the United States.

    Learn More
  • Reimbursement Key to Making CAR T-Cell Therapy Accessible

    The Association for Clinical Oncology submitted comments to the Centers for Medicare & Medicaid Services in response to the FY 2021 Hospital Inpatient Prospective Payment System proposed rule, which would establish a new Medicare Severity Diagnosis Related Group for CAR T-cell immunotherapies.

    Read More
  • States Fight for Medicaid Coverage of Routine Care Costs

    The Association for Clinical Oncology continues to advocate for federal and state legislative action to guarantee Medicaid coverage of routine care costs for clinical trial participants.

    Get Involved

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15